| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |